MedTrace Logo

Exploration of Blood Biomarkers, Including Whole Blood Viscosity as a Prognostic Factor for Acute Pancreatitis

NCT04553783 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 137

Last updated 2020-09-17

No results posted yet for this study

Summary

This study aims to evaluate the usefulness of blood viscosity as a prognostic factor in patients with acute pancreatitis. The study design is a single-arm prospective cohort observational study. Blood biomarkers including blood viscosity, C-reactive protein, hematocrit, and phosphate are measured and the correlation with the severity of acute pancreatitis will be analyzed.

Conditions

Sponsors & Collaborators

  • In Seok Lee

    lead OTHER

Principal Investigators

  • In Seok Lee, MD, PhD · Seoul St. Mary's Hospital

Eligibility

Min Age
19 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-03-10
Primary Completion
2022-05-31
Completion
2023-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04553783 on ClinicalTrials.gov